Research on albinism is crucial for improving the quality of life, health, and social inclusion of individuals with this condition. By studying the genetic causes and visual impairments associated with albinism, such as nystagmus and reduced melanin affecting vision and skin protection, researchers can develop targeted treatments and interventions. Advances in understanding albinism also help […]
Read MoreDecember 8, 2024
Research Progress Related to Vitiligo
Research on vitiligo provides significant benefits, advancing understanding of this complex autoimmune skin condition that causes patches of skin to lose pigment. By investigating the genetic, immunological, and environmental factors involved, researchers can develop more effective treatments and potential cures, improving quality of life for those affected. Additionally, research helps to raise awareness, reduce stigma, […]
Read MoreDecember 8, 2024
The Annual Open Enrollment for Medicare began on October 15 and ends on December 7, 2024 for coverage beginning January 1, 2025. The CSD, in partnership with the Medicare Access for Patients Rx (MAPRx) Coalition, has created a Medicare Part D prescription drug open enrollment guide and patient guide for our members, as well as an infographic. Congress recently made changes to […] October 28, 2024 2025 Medicare Enrollment Resources